EML share price soars 11% amid takeover attention

EML Payment shares have jumped after the company confirmed there have been takeover talks.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • The EML share price has gone bananas this morning
  • The payments company confirmed that there had been takeover interest from Bain Capital
  • However, the private equity group has walked away

The EML Payments Ltd (ASX: EML) share price is up more than 11% at the time of writing after the company confirmed it has been in takeover talks.

In a statement to the ASX, EML noted media speculation that the business has been subject to takeover interest from private investment group Bain Capital.

Woman attached to rocket flies into the air

Image source: Getty Images

How close is a takeover for EML?

EML confirmed that it had been in talks with Bain Capital earlier in the year about a potential takeover proposal. However, those discussions have now ceased.

The board of EML said that it would always consider proposals presented to the company and that it's fully committed to acting in the best interests of shareholders. The goal of EML's board is to maximise value for shareholders, the company said.

While no deal happened, EML disclosed that it appointed Goldman Sachs as its financial advisor and Herbert Smith Freehills as its legal advisor.

What happens now?

According to reporting by the Australian Financial Review, sources indicated that Bain has walked away "for now" because of the high price tag after looking at the due diligence numbers.

Time will tell whether this activates other interested parties to start having a look at the global payments business.

The EML share price has fallen by 10% in 2022 to date, including today's rise.

However, over the last year, the EML share price still registers a decline of 48%.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended EML Payments. The Motley Fool Australia owns and has recommended EML Payments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Kingsgate, Neuren, Newcrest, and Pushpay shares are rising today

These ASX shares are avoiding the market selloff on Tuesday.

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Neuren, Northern Star, Race Oncology, and Westgold shares are storming higher

These ASX shares are starting the week in a positive fashion.

Read more »

A woman wearing yellow smiles and drinks coffee while on laptop.
Share Gainers

Why APM, Macquarie Telecom, Northern Star, and Origin shares are rising today

These ASX shares are having a strong session despite the market selloff.

Read more »

Two boys with cardboard rockets strapped to their backs, indicating two ASX companies with rocketing share prices
Share Gainers

Catch these fast-rising 2 ASX shares before it's too late: Celeste

This pair of stocks rocketed up in February during reporting season, but are still great value for those willing to…

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Share Gainers

Why Arafura, Myer, Volpara, and Xero shares are zooming higher

These ASX shares are making their shareholders smile on Thursday.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano shares are charging higher

These ASX shares are having a strong session despite the market selloff.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why InvoCare, Pentanet, Sayona Mining, and Weebit Nano shares are storming higher

These ASX shares are having a strong session on Tuesday.

Read more »